Frontiers in Microbiology (May 2022)
Characteristics of 24 SARS-CoV-2-Sequenced Reinfection Cases in a Tertiary Hospital in Spain
- Blanca Borras-Bermejo,
- Maria Piñana,
- Maria Piñana,
- Cristina Andrés,
- Cristina Andrés,
- Ricardo Zules,
- Alejandra González-Sánchez,
- Alejandra González-Sánchez,
- Juliana Esperalba,
- Juliana Esperalba,
- Oleguer Parés-Badell,
- Damir García-Cehic,
- Damir García-Cehic,
- Ariadna Rando,
- Ariadna Rando,
- Carolina Campos,
- Maria Gema Codina,
- Maria Gema Codina,
- Maria Carmen Martín,
- Carla Castillo,
- Karen García-Comuñas,
- Rodrigo Vásquez-Mercado,
- Reginald Martins-Martins,
- Sergi Colomer-Castell,
- Tomàs Pumarola,
- Tomàs Pumarola,
- Magda Campins,
- Josep Quer,
- Josep Quer,
- Andrés Antón,
- Andrés Antón
Affiliations
- Blanca Borras-Bermejo
- Department of Preventive Medicine and Epidemiology, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
- Maria Piñana
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Maria Piñana
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Cristina Andrés
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Cristina Andrés
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Ricardo Zules
- Department of Preventive Medicine and Epidemiology, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
- Alejandra González-Sánchez
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Alejandra González-Sánchez
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Juliana Esperalba
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Juliana Esperalba
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Oleguer Parés-Badell
- Department of Preventive Medicine and Epidemiology, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
- Damir García-Cehic
- Liver Diseases-Viral Hepatitis, Liver Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain
- Damir García-Cehic
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain
- Ariadna Rando
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Ariadna Rando
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Carolina Campos
- Liver Diseases-Viral Hepatitis, Liver Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain
- Maria Gema Codina
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Maria Gema Codina
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Maria Carmen Martín
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Carla Castillo
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Karen García-Comuñas
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Rodrigo Vásquez-Mercado
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Reginald Martins-Martins
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Sergi Colomer-Castell
- Liver Diseases-Viral Hepatitis, Liver Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain
- Tomàs Pumarola
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Tomàs Pumarola
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- Magda Campins
- Department of Preventive Medicine and Epidemiology, Vall d’Hebron Research Institute, Universitat Autònoma de Barcelona, Barcelona, Spain
- Josep Quer
- Liver Diseases-Viral Hepatitis, Liver Unit, Vall d’Hebron Institut de Recerca, Barcelona, Spain
- Josep Quer
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Instituto de Salud Carlos III, Madrid, Spain
- Andrés Antón
- Respiratory Viruses Unit, Virology Section, Microbiology Department, Vall d’Hebron Institut de Recerca (VHIR), Vall d’Hebron Barcelona Hospital Campus, Vall d’Hebron Hospital Universitari, Barcelona, Spain
- Andrés Antón
- CIBERINFEC, ISCIII-CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain
- DOI
- https://doi.org/10.3389/fmicb.2022.876409
- Journal volume & issue
-
Vol. 13
Abstract
BackgroundSince the emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the main concern is whether reinfections are possible, and which are the associated risk factors. This study aims to describe the clinical and molecular characteristics of 24 sequence-confirmed reinfection SARS-CoV-2 cases over 1 year in Barcelona (Catalonia, Spain).MethodsPatients with > 45 days between two positive PCR tests regardless of symptoms and negative tests between episodes were initially considered as suspected reinfection cases from November 2020 to May 2021. Whole-genome sequencing (WGS) was performed to confirm genetic differences between consensus sequences and for phylogenetic studies based on PANGOLIN nomenclature. Reinfections were confirmed by the number of mutations, change in lineage, or epidemiological criteria.ResultsFrom 39 reported suspected reinfection cases, complete viral genomes could be sequenced from both episodes of 24 patients, all were confirmed as true reinfections. With a median age of 44 years (interquartile range [IQR] 32–65), 66% were women and 58% were healthcare workers (HCWs). The median days between episodes were 122 (IQR 72–199), occurring one-third within 3 months. Reinfection episodes were frequently asymptomatic and less severe than primary infections. The absence of seroconversion was associated with symptomatic reinfections. Only one case was reinfected with a variant of concern (VOC).ConclusionSevere acute respiratory syndrome coronavirus 2 reinfections can occur in a shorter time than previously reported and are mainly found in immunocompetent patients. Surveillance through WGS is useful to identify viral mutations associated with immune evasion.
Keywords